NL-OMON24419尚未招募不适用
Molecular Imaging with Fluor-18 PSMA-1007 PET/CT for lymph Node sTaging in primary prostate cancer
Canisius Wilhelmina ZiekenhuisWeg door Jonkerbos 1006532 SZ NijmegenThe Netherlands0 个研究点目标入组 100 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 100
研究概览
简要总结
ot applicable
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1.Biopsy proven adenocarcinoma of the prostate;
- •2.Indication for (super)extended pelvic lymph node dissection (PLND - with or without robot-assisted laparoscopic prostatectomy);
排除标准
- •1.History of prior diagnosed or treated PCa.
- •2.Known concomitant malignancies (except Basal Cell Carcinoma of the skin).
研究者
相似试验
终止
2 期
A Study of [18]F-PSMA-1007 in Patients With Known or Suspected Metastatic Prostate CancerOncologyProstate CancerNCT05712174AHS Cancer Control Alberta176
已完成
1 期
Positron emission tomography using a newly-developed PET probe: [18F] Fluoroacetate (FACE) - human volunteer studyhealthy volunteerJPRN-UMIN000007575Shiga Medical Center Research Institute4
撤回
不适用
Study of 18F-FEC for Positron Emission Tomography-Computed Tomography (PET-CT) Imaging of GBMAstrocytoma, Grade IVGiant Cell GlioblastomaGlioblastoma MultiformeNCT00943462Centre hospitalier de l'Université de Montréal (CHUM)
已完成
3 期
Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate CancerProstate Cancer RecurrentProstate CancerNCT04742361ABX advanced biochemical compounds GmbH136
尚未招募
不适用
Molecular-guided PET/MRI (Positron Emission Tomography/Magnetic Resonance Imaging) to target hypoxia in Glioblastoma (GBM): A Pilot Study.GlioblastomaACTRN12617000815369Royal Brisbane and Women's Hospital5